A5102923454- Antibiotic Resistance in Bacteria
- Antibiotic Use and Resistance
- Urinary Tract Infections Management
- vaccines and immunoinformatics approaches
- Bacillus and Francisella bacterial research
- Bacterial biofilms and quorum sensing
- SARS-CoV-2 and COVID-19 Research
Foundation University Islamabad
2024
AbstractAbstractResistance rates to amikacin, ciprofloxacin, ceftazidime, cefepime, imipenem, cefoperazone/sulbactam and piperacillin/tazobactam in Escherichia coli (n= 438)Klebsiella pneumoniae 444)Pseudomonas aeruginosa 210) Acinetobacterbaumanni (n=200) were determined with e-test a multicenter surveillance study (HITIT-2) 2007. ESBL production K. was investigated following the CLSI guidelines. Overall 42.0% of E.coli 41.4% producers. In E. coli, resistance imipenem not observed,...
The COVID-19 pandemic has increased demand for effective diagnostics, and extensive research been conducted on the N-terminal domain (NTD) receptor-binding (RBD) of SARS-CoV-2 spike glycoprotein, which are critical viral binding. This study focuses expression NTD RBD in pyrG auxotrophic Aspergillus oryzae first time. Recombinant were expressed as glucoamylase-fusion proteins purified using metal affinity chromatography. Size-exclusion chromatography was used to confirm correct folding purity...